TrialOpen forum infectious diseases2024

COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)-a Randomized Controlled Clinical Trial.

Michelle Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.